Population pharmacokinetic meta-analysis and dosing recommendation for meropenem in critically ill patients receiving continuous renal replacement therapy
Y Peng, Z Cheng, F Xie - Antimicrobial Agents and Chemotherapy, 2022 - Am Soc Microbiol
The optimal dosing regimen for meropenem in critically ill patients undergoing continuous
renal replacement therapy (CRRT) remains undefined due to small studied sample sizes …
renal replacement therapy (CRRT) remains undefined due to small studied sample sizes …
Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial
G Monti, N Bradić, M Marzaroli, A Konkayev… - Jama, 2023 - jamanetwork.com
Importance Meropenem is a widely prescribed β-lactam antibiotic. Meropenem exhibits
maximum pharmacodynamic efficacy when given by continuous infusion to deliver constant …
maximum pharmacodynamic efficacy when given by continuous infusion to deliver constant …
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
U Liebchen, H Salletmeier, S Kallee, C Scharf… - Scientific reports, 2021 - nature.com
The aim of this study was to investigate optimal loading doses prior to continuous infusion of
meropenem in critically ill patients. A previously published and successfully evaluated …
meropenem in critically ill patients. A previously published and successfully evaluated …
Continuous infusion versus intermittent administration of meropenem in critically ill patients
F Thalhammer, F Traunmüller… - Journal of …, 1999 - academic.oup.com
This prospective crossover study compared the pharmacokinetics of meropenem by
continuous infusion and by intermittent administration in critically ill patients. Fifteen patients …
continuous infusion and by intermittent administration in critically ill patients. Fifteen patients …
Meropenem model-informed precision dosing in the treatment of critically ill patients: can we use it?
The number of pharmacokinetic (PK) models of meropenem is increasing. However, the
daily role of these PK models in the clinic remains unclear, especially for critically ill patients …
daily role of these PK models in the clinic remains unclear, especially for critically ill patients …
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
I Chytra, M Stepan, J Benes, P Pelnar, A Zidkova… - Critical care, 2012 - Springer
Introduction Meropenem bactericidal activity depends on the time when the free drug
concentrations remain above the minimum inhibitory concentration of pathogens. The goal …
concentrations remain above the minimum inhibitory concentration of pathogens. The goal …
Evaluation of empirical dosing regimens for meropenem in intensive care unit patients using population pharmacokinetic modeling and target attainment analysis
In the present study, population pharmacokinetic (PK) analysis was performed based on
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …
Optimization of meropenem dosage in the critically ill population based on renal function
JL Crandon, RE Ariano, SA Zelenitsky, AM Nicasio… - Intensive care …, 2011 - Springer
Purpose To develop a meropenem population pharmacokinetic model in critically ill patients
with particular focus on optimizing dosing regimens based on renal function. Methods …
with particular focus on optimizing dosing regimens based on renal function. Methods …
Meropenem pharmacokinetics and target attainment in critically ill patients are not affected by extracorporeal membrane oxygenation: a matched cohort analysis
Existing evidence is inconclusive whether meropenem dosing should be adjusted in
patients receiving extracorporeal membrane oxygenation (ECMO). Therefore, the aim of this …
patients receiving extracorporeal membrane oxygenation (ECMO). Therefore, the aim of this …
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study
L Ehmann, M Zoller, IK Minichmayr, C Scharf, B Maier… - Critical care, 2017 - Springer
Background Severe bacterial infections remain a major challenge in intensive care units
because of their high prevalence and mortality. Adequate antibiotic exposure has been …
because of their high prevalence and mortality. Adequate antibiotic exposure has been …